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Abstract
We previously developed an antibody-avidin fusion protein (ch128.1Av) that targets the human
transferrin receptor 1 (TfR1) and exhibits direct cytotoxicity against malignant B cells in an iron-
dependent manner. ch128.1Av is also a delivery system and its conjugation with biotinylated
saporin (b-SO6), a plant ribosome-inactivating toxin, results in a dramatic iron-independent
cytotoxicity, both in malignant cells that are sensitive or resistant to ch128.1Av alone, in which
the toxin effectively inhibits protein synthesis and triggers caspase activation. We have now found
that the ch128.1Av/b-SO6 complex induces a transcriptional response consistent with oxidative
stress and DNA damage, a response that is not observed with ch128.1Av alone. Furthermore, we
show that the antioxidant N-acetylcysteine partially blocks saporin-induced apoptosis suggesting
that oxidative stress contributes to DNA damage and ultimately saporin-induced cell death.
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Interestingly, the toxin was detected in nuclear extracts by immunoblotting, suggesting the
possibility that saporin might induce direct DNA damage. However, confocal microscopy did not
show a clear and consistent pattern of intranuclear localization. Finally, using the long-term
culture-initiating cell assay we found that ch128.1Av/b-SO6 is not toxic to normal human
hematopoietic stem cells suggesting that this critical cell population would be preserved in
therapeutic interventions using this immunotoxin.
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Introduction
Saporin is a ribosome-inactivating proein (RIP) isolated from the plant Saponaria officinalis
that strongly blocks protein synthesis (Lombardi et al. 2010). It is a Type I RIP in that it
consists of a single catalytic polypeptide chain and lacks a cell-binding chain. It has similar
catalytic activity to that of ricin, a Type II RIP that consists of both the catalytic and cell-
binding domains (de Virgilio et al. 2010). RIPs are N-glycosidases that depurinate specific
adenine residues of the 23S/25S/28S ribosomal subunits leading to the irreversible block in
protein synthesis. Saporin has also been reported to have DNase-like activity (Gasperi-
Campani et al. 2005; Roncuzzi and Gasperi-Campani 1996), although this is controversial
(Lombardi et al. 2010). It has also been reported that the glycosidase activity of saporin is
not required for its cytotoxicity (Cimini et al. 2011; Sikriwal et al. 2008). There are several
isoforms of saporin that have been identified and named based on the tissue of origin and
chromatographic peak in ion-exchange chromatography (Lombardi et al. 2010). Saporin-6
(SO6), one of the most active forms of the toxin, is produced in the seeds of the plant and
represents the major peak (peak 6) in chromatography analysis of seed extracts (Lombardi et
al. 2010). This peak contains up to 4 different isoforms of the toxin that has either an
aspartic or glutamic acid residue in position 48 and either a lysine or arginine residue at
position 91. Due to its high cytotoxicity, high stability and resistance to denaturation
(Santanche et al. 1997), and inability to readily enter cells, saporin is a promising therapeutic
agent for delivery into cancer cells.
An antibody-avidin fusion protein (ch128.1Av) was previously produced as a delivery
system for a broad range of biotinylated therapeutic agents, such as SO6, into cancer cells
(Daniels et al. 2007; Ng et al. 2002; Ng et al. 2006). This fusion protein contains avidin
genetically fused to the CH3 domains of the human IgG3 heavy chains. The antibody is
specific for the human transferrin receptor 1 (TfR1, also known as CD71) and does not
compete with the endogenous ligand transferrin (Tf) for receptor binding (Ng et al. 2006;
Rodriguez et al. 2007). The TfR1 is a Type II transmembrane homodimeric protein involved
in iron uptake and regulation of cell growth (Daniels et al. 2006b). It is widely expressed at
low levels on many cell types, but shows increased expression on rapidly dividing cells
including malignant cells due to their increased need for iron (Daniels et al. 2006b). Because
of its central role in cancer pathology, its accessibility on the cell surface, and its ability to
internalize through receptor-mediated endocytosis, the TfR1 has been used for the targeted
delivery of numerous different therapeutic agents into cancer cells (Daniels et al. 2012;
Daniels et al. 2006a). The TfR1 can be targeted in two ways, either through the use of
conjugates containing Tf, or through the use of antibodies like ch128.1Av. In addition to its
delivery potential, ch128.1Av is cytotoxic to certain human malignant B cells, including
multiple myeloma (MM) and non-Hodgkin’s lymphoma (NHL) cells (Ng et al. 2002; Ng et
al. 2006; Ortiz-Sanchez et al. 2009), an activity that is higher compared to that of its parental
antibody (ch128.1) without avidin (Daniels et al. 2011; Ng et al. 2006). This activity is due
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to an alteration in the TfR cycling pathway, increased TfR degradation, and the induction of
lethal iron starvation in sensitive cells (Daniels et al. 2007; Ng et al. 2006; Rodriguez et al.
2011). However, both ch128.1Av and its parental antibody demonstrated in vivo anti-cancer
activity in two xenograft mouse models of disseminated human MM (Daniels et al. 2011).
Taken together, ch128.1Av is a versatile approach for the treatment of B-cell malignancies
in that it can be directly cytotoxic through the disruption of iron metabolism or it can be
used as a universal delivery system for many therapeutic agents.
Previously we have shown that ch128.1Av delivers the active b-SO6 toxin into human
malignant B cells resulting in protein synthesis inhibition, caspase activation (especially
caspases 2 and 3), and the induction of apoptosis in both cells that are sensitive to the fusion
protein alone and those that are resistant (Daniels et al. 2007). The cytotoxicity of b-SO6
conjugated to ch128.1Av in cells that are sensitive to the direct effects of ch128.1Av occurs
much faster than that of the ch128.1Av alone. Additionally, the cytotoxicity of the conjugate
could not be blocked by the addition of excess iron (Daniels et al. 2007), indicating that in
contrast to ch128.1Av alone, iron starvation does not play a role in this cell death. These
data suggest that the death induced by the conjugate is exclusively mediated by the toxin and
not the direct cytotoxic effects of the fusion protein. A previous report on the gene
expression analysis of ch128.1Av alone showed a transcriptional response consistent with
iron deprivation mediated in part by p53 (Rodriguez et al. 2011). We now show that the
ch128.1Av/b-SO6 immunotoxin induces a different transcriptional response, which is
consistent with the induction of oxidative stress and DNA damage. The induction of lethal
oxidative stress was confirmed through the analysis of cell death in the presence of an
antioxidant. In addition, we have conducted studies that suggest nuclear localization of the
toxin. Finally, we found that ch128.1Av/b-SO6 does not show toxicity to normal human
hematopoietic stem cells or non-committed (early) progenitor cells.
Materials and Methods
Cell Lines
IM-9 (a human EBV-transformed B-lymphoblastoid cell line) and U266 (a human MM cell
line) were purchased from the American Type Culture Collection (ATCC, Manassas, VA).
Both malignant B-cell lines were grown in RPMI 1640 medium (Life Technologies,
Carlsbad, CA) supplemented with 10% heat inactivated fetal bovine serum (Atlanta
Biologicals Inc., Lawrenceville, GA) and grown in 5% CO2 and 37°C.
Recombinant antibody-avidin fusion protein production and immunotoxin formation
The antibody-avidin fusion protein ch128.1Av (formerly known as anti-human TfR IgG3-
Av) has been previously described (Ng et al. 2002; Ng et al. 2006). It consists of a mouse/
human chimeric IgG3 antibody genetically fused to avidin via its CH3 domains. The IgG3
contains the variable regions of the murine antibody 128.1. A similar non-targeting isotype
control fusion protein specific for the hapten dansyl (DNS): 5-dimethylamino
naphthalene-1-sulfonyl chloride (IgG3-Av) has been previously reported (Ng et al. 2006).
Both fusion proteins, expressed in murine myeloma cells, were purified from cell culture
supernatants using affinity chromatography. Proteins were dialyzed into buffer (150 mM
NaCl, 50 mM Tris-HCl, pH 7.8) and protein concentrations were determined by the
bicinchoninic acid (BCA) Protein Assay (Thermo Fisher Scientfic, Walnut, CA). Mono-
biotinylated saporin (b-SO6, mw ~30 kDa) was purchased from Advanced Targeting
Systems (San Diego, CA) as a custom conjugate of one biotin per toxin molecule.
ch128.1Av or IgG3-Av was conjugated to b-SO6 in a 1:1 molar ratio on ice for 30 minutes
before the addition to cell culture medium as previously described (Daniels et al. 2007).
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Microarray hybridization and data quality control
IM-9 and U266 cells were incubated for 1, 3, 9, or 24 hours with 10 nM ch128.1Av alone or
conjugated to b-SO6. Control samples consisted of cells incubated with an equal volume of
buffer alone for the same time points. Total mRNA was collected from all samples using the
RNeasy Kit (Qiagen, Valencia, CA). RNA was quantified and the integrity evaluated using a
Agilent 2100 Bioanalyzer (Agilent Technologies, Inc., Santa Clara, CA). RNA was
hybridized onto HumanRef-8 v2 Expression BeadChips (Illumina, Inc., San Diego, CA) and
global gene expression profiles for these samples were collected using the BeadArray
software package (Illumina). Quality control, preprocessing, data normalization, and
statistical analysis of differential expression was performed as described previously
(Rodriguez et al. 2011). All changes were deemed significant (p < 0.05) based on a
regularized Bayesian test. Data for ch128.1Av-treated cells has already been reported
(Rodriguez et al. 2011).
Proliferation and apoptosis assays
IM-9 and U266 cells were incubated for 48 hours with 10 nM ch128.1Av alone or
conjugated to b-SO6. Control cells were incubated with an equal volume of buffer alone.
Inhibition of cell proliferation was monitored using the [3H]-thymidine incorporation assay
as previously described (Daniels et al. 2007). Apoptosis was assessed using Annexin V
staining and flow cytometry as described previously (Daniels et al. 2007). For antioxidant
studies, IM-9 and U266 cells were treated with 10 or 1 nM ch128.1Av, b-SO6, or the
ch128.1Av/b-SO6 complex in the presence or absence of 2 mM of the antioxidant N-
acetylcysteine (NAC) for 48 hours. As a commonly used protein synthesis inhibitor, cells
were treated with cycloheximide (CHX, ThermoFisher Scientific, Walnut, CA). Different
concentrations of CHX were used for the two cell lines since U226 can be resistant to
apoptosis due to the high level of Bcl-xL expression (Catlett-Falcone et al. 1999). U266
cells were treated with either 100 or 10 μg/mL CHX and IM-9 cells were treated with 1.0 or
0.1 μg/mL CHX (in the presence or absence of 2 mM NAC). Apoptosis was then assessed
by flow cytometry. Ten thousand events were recorded for each sample on a Becton–
Dickinson FACScan Analytic Flow Cytometer (BD Biosciences, San Jose, CA) in the
UCLA Jonsson Comprehensive Cancer Center and Center for AIDS Research Flow
Cytometry Core Facility. Data were analyzed using the FCS Express V3 software (De Novo
Software, Los Angeles, CA).
Validation by real time, quantitative PCR (QPCR)
New RNA samples were collected using the RNeasy Kit (Qiagen) from IM-9 and U266 cells
treated with either 10 nM ch128.1Av, b-SO6, or the ch128.1Av/b-SO6 complex for 24
hours. U266 and IM-9 cells were also treated with 100 μg/mL or 1.0 μg/mL CHX,
respectively, for 24 hours as a control protein synthesis inhibitor. cDNA was prepared using
2 μg of RNA and the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems,
Carlsbad, CA) according to the manufacturer’s protocol. For all QPCR reactions, cDNA
samples were diluted 1:100 since this dilution was pre-determined to be overall the best for
target and housekeeping genes in untreated cells. The Universal Probe Library Real Time
PCR System (Roche Applied Science, Indianapolis, IN) was used for validation of gene
expression. This system uses sequence-specific primers that recognize the gene of interest as
well as fluorescently labeled probes that attach to the piece of DNA that is being amplified.
The online Assay Design Center (Roche Applied Science) that uses the gene accession
numbers was used to identify the universal probe and primer sequences for each reaction.
This information is given in Table 1. Primers were synthesized by Integrated DNA
Technologies (Coralville, IA). The GAPDH reference gene kit labeled with Yellow555
(Roche Applied Science) was used as a housekeeping gene. All other probes were labeled
with FAM. Real time PCR reactions (total volume of 20 μL) were prepared using the
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LightCycler 480 Probes Master Mix (Roche Applied Science) as instructed by the
manufacturer and run on the LightCycler 480 in the GenoSeq UCLA Genotyping and
Sequencing core facility. The LightCycler 1.5 Software (Roche Applied Science) was used
to analyze all data. This software uses the ΔΔCT method to calculate the fold change in
gene expression compared to the reference gene in treated versus control cells treated with
buffer alone.
Confocal microscopy
ch128.1Av (10 nM) conjugated to b-SO6 was labeled with Zenon® (excitation 594 nm; Life
Technologies) and the labeled complex was incubated with IM-9 or U266 cells for 1 or 16
hours. Cells were collected, fixed with 3.7% paraformaldehyde, permeabilized with 0.2%
Triton-X and incubated with a goat anti-saporin antibody labeled with Alexa Fluor® 488
(Advanced Targeting Systems) for at least 2 hours followed by the anti-goat IgG labeled
with Alexa Fluor® 488 (Life Technologies) for 1 hour. After washing, cells were mounted
on slides in Vectashield® mounting medium with 1.5 μg/mL DAPI (Vector Labs,
Burlingame, CA). Images were obtained using a confocal microscope (Leica, Wetzlar,
Germany) equipped with an oil-immersion NA 1.4 60X objective. Images were analyzed
using ImageJ software (NIH). Confocal laser scanning microscopy was performed in the
California NanoSystems Institute Advanced Light Microscopy/Spectroscopy Shared
Resource Facility at UCLA.
Western Blot analysis of nuclear extracts
Both IM-9 and U266 cells were treated in 60 mm dishes with 10 nM ch128.1Av/b-SO6 for
either 1 or 16 hours. Nuclear and cytoplasmic extracts were prepared using the Nuclear
Extract Kit (Active Motif, Carlsbad, CA) as described by the manufacturer. Control cells
were incubated with an equal volume of buffer alone. Protein concentrations were
determined using the BCA protein assay (Thermo Fisher Scientfic). Proteins (20 μg for
cytoplasmic fractions and 2 μg for nuclear extracts) were then separated on 4–12% Bis-Tris
NuPAGE gels (Life Technologeis) in MOPS buffer. Proteins were transferred to Whatman
Protran nitrocellulose membranes (Thermo Fisher Scientific) and probed with a goat anti-
saporin antibody labeled with horseradish peroxidase (HRP; Advanced Targeting Systems).
A rabbit anti-human GAPDH antibody (Cell Signaling Technology, Boston, MA) was used
as a control for cytoplasmic protein and was detected using a donkey anti-rabbit IgG-HRP
(GE Healthcare Life Sciences, Piscataway, NJ). The murine antibody targeting the human
TATA-box binding protein (TBP; Life Technologies) was used as a nuclear protein control
as previously described (Dansithong et al. 2008) and was detected using a sheep anti-mouse
IgG-HRP antibody (GE Healthcare Life Sciences). For all Western Blots the ChemiGlow
West Chemiluminescent Substrate (ProteinSimple, San Jose, CA) was used as described by
the manufacturer and blots were developed on a Kodak X-OMAT 2000A (Rochester, NY).
Long-term culture-initiating cell assay (LTC-IC)
Bone marrow mononuclear cells (BMMC, StemCell Technologies, Vancouver, Canada)
were treated with 10 nM ch128.1Av, b-SO6, ch128.1Av/b-SO6 or IgG3-Av/b-SO6 for 1
hour in Iscove’s Modfied Dulbecco’s Medium with 2% FBS. Cells were then washed 3
times and the assay was carried out as recommended in the LTC-IC Procedure Manual
(StemCell Technologies) and as described previously (Daniels et al. 2011). In brief, treated
cells were seeded on a M2-10B4 murine fibroblast (ATCC) feeder layer in human long-term
medium (StemCell Technologies). Cells were cultured for 5 weeks with half media changes
weekly. Both nonadherent and adherent cells were harvested and seeded in quadruplicate in
MethoCult GF+H4435 (“Complete PLUS” methylcellulose medium with recombinant
cytokines and erythropoietin; StemCell Technologies). After an 18-day incubation total
colony numbers were determined using an Olympus CK2 inverted microscope (Olympus
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America Inc., Center Valley, PA). The assay was conducted using BMMC from 3 different
donors.
Results
Global gene expression analysis in cells treated with the ch128.1Av/b-SO6 conjugate
Two cell lines were chosen for the global gene expression analysis. IM-9 cells are highly
sensitive to the effects of the fusion protein alone, while U266 cells are resistant (Daniels et
al. 2007; Ng et al. 2006; Rodriguez et al. 2011). Both malignant B-cell lines have been
previously shown to be sensitive to apoptosis-induced by the ch128.1Av/b-SO6 conjugate
(Daniels et al. 2007). RNA was collected for analysis from both cells lines at various time
points after treatment with ch128.1Av/b-SO6 (Figure 1A). Cells incubated with buffer alone
were used as controls. Treated cells were also monitored simultaneously for the expected
cytotoxic effects at 48 hours using proliferation and apoptosis assays (Figure 1B–C). As
expected, ch128.1Av was only cytotoxic to IM-9 cells, while both cell lines were sensitive
to the effects of the conjugate.
HumanRef-8 v2 Expression BeadChips were used to monitor gene expression changes. The
data normalization process is described and shown in Supplementary Figure 1. The number
of differentially expressed genes (LFC > 1, p < 0.05) in IM-9 cells was higher than those of
U266. Most of the changes in IM-9 cells occurred at 9 and 24 hours and included both up
and down regulation of genes (Figure 2A). Limited changes were detected in U266 cells
treated with the conjugate and all changes were upregulation of the specified genes (Figure
2B). A focused view of the expressional changes (LFC > 1, p < 0.05) that occurred in IM-9
cells after 9 hours of treatment with the conjugate (compared to buffer alone) is shown in
Figure 2C. Gene expression changes (LFC > 1, p < 0.05) in the two cells lines for the same
treatment times are compared in Figure 3 and ontologies are shown in Figure 4. A Venn
diagram (Supplementary Figure 2) shows the gene expression changes that were observed in
IM-9 and U266 cells. A set of 11 genes were upregulated in both cell lines: TXNIP,
CDC14B, HIST2H4, RGS1, THUMPD2, KLF6, BHLHB1, FYTTD1, GADD45B,
TSC22D3, and NFKBIE. No genes were found to be downregulated in both cell lines. The
expression levels of these 11 genes were further analyzed by QPCR to confirm the gene
expression changes (Figure 5, Table 2). In the QPCR analysis, the changes observed in the
11 genes in IM-9 cells were of higher magnitude than those of U266 and were consistent
with the microarray data. All 11 genes tested by QPCR showed upregulation upon treatment
with the ch128.1Av/b-SO6 conjugate, but not with the fusion protein or the toxin alone.
These genes are different from those that were previously shown to be differentially
expressed in response to the fusion protein alone, which are consistent with a response to
iron deprivation (Rodriguez et al. 2011). However, 10 of the genes were also upregulated in
both cell lines upon treatment with the commonly used protein synthesis inhibitor CHX
(Supplementary Table 1). HIST2H4 was the only gene not consistently upregulated by CHX
in both cell lines. Thus, this transcriptional response appears to be in response to protein
synthesis inhibition in general and not a specific response to the ch128.1Av/b-SO6
conjugate.
The effect of the antioxidant N-acetylcysteine on saporin-induced apoptosis
The gene expression profile of IM-9 and U266 cells treated with the ch128.1Av/b-SO6
conjugate is consistent with the induction of oxidative stress and DNA damage triggered by
the toxin. In order to examine whether oxidative stress plays a role in the apoptosis mediated
by the toxin, the antioxidant NAC was co-incubated with the conjugate or CHX for the full
48 hours and apoptosis assessed. Cells were treated with 1nM ch128.1Av/b-SO6 since this
concentration consistently induces a high level of apoptosis in both cell lines. Additionally,
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we used a high concentration (10 nM) of the conjugate as to determine if the effects of NAC
were dose-dependent. We also used a high and a low dose of CHX. As expected, ch128.1Av
alone had no effect on U266 cells. In IM-9 cells ch128.1Av had an effect that was not
blocked by NAC. However, in both cell lines ch128.1Av/b-SO6 strongly induced apoptosis
that could be blocked by NAC in a dose-dependent manner (Figure 6). CHX induced
apoptosis in both cell lines; however, NAC did not block this cell death.
Analysis of saporin localization
To address the possibility that b-SO6 can cause direct DNA damage upon delivery by
ch128.1Av into the cells, we performed localization studies by confocal microscopy. If
saporin is found within the nucleus, it would be possible that the toxin can cause direct DNA
damage. Therefore, we followed the internalization of ch128.1Av/b-SO6 in IM-9
(Supplementary Figure 3) and U266 (Supplementary Figure 4) cells over a 24-hour period.
The ch128.1Av/b-SO6 complex was intracellularly localized after 30 minutes. The complex
was seen in punctate structures in the cytoplasm and accumulated around the nucleus. The
toxin appeared to colocalize with ch128.1Av; however, no strong intranuclear localization of
saporin was detected by confocal microscopy at any time point tested. Nevertheless,
Western Blot analysis showed that the toxin was detected in nuclear extracts in both IM-9
and U266 cells as early as 1 hour after treatment (Figure 7). After 16 hours post-exposure,
there appeared to be higher levels of b-SO6 in the nuclear extracts.
In vitro toxicity to hematopoietic stem cells and early progenitors
Since the ch128.1Av/b-SO6 conjugate targets malignant hematopoietic cancers via
interaction with TfR1, we evaluated the potential toxicity of the conjugate on normal
hematopoietic stem and early progenitor cells using the long-term cell-initiating culture
(LTC-IC) assay. The LT-IC assay enumerates the number of or pluripotent hematopoietic
stem and noncommitted, early progenitor cells within a given sample. The number of
colonies at the end of the assay correlates with the number of viable pluripotent progenitor
cells after treatment. Exposure to ch128.1Av/b-SO6 did not result in a reduction of colony
number (Table 3) when we tested BMMC from 3 different donors, suggesting that the
conjugate is not toxic to this population of cells. ch128.1Av or b-SO6 alone, as well as the
isotype control conjugate (IgG3-Av/b-SO6), also did not affect colony formation.
Discussion
We have previously shown that the delivery of the single chain RIP b-SO6 using ch128.1Av
effectively blocks protein synthesis, activates caspases 2 and 3, and to lesser extent caspases
8 and 9, and induces apoptosis in malignant B cells (Daniels et al. 2007). In order to further
explore the mechanism of cell-death induced by this immunotoxin, we conducted a global
gene expression analysis in two different human malignant B-cell lines, one that is sensitive
to the cytotoxic effects of the fusion protein alone (IM-9) and one that is not (U266). Eleven
genes that were differentially expressed in both cell lines were identified. Since these genes
were similarly activated in both cell lines, they may represent a generalized response to the
toxin in malignant B cells. The proteins encoded by 11 genes upregulated in both cell lines
in response to the immuntoxin are involved in the cellular response to oxidative stress, DNA
damage, or are involved with RNA processing. KLF6 is a zinc finger-containing
transcription factor whose expression increases upon treatment with hydrogen peroxide
(Cullingford et al. 2008; Ghaleb and Yang 2008). It also acts as a tumor suppressor that has
been shown to interact with Cyclin D1 causing cell cycle arrest (Benzeno et al. 2004).
TXNIP can also act as a tumor suppressor and plays a role in redox homeostasis through its
interaction with the antioxidant thioredoxin (Zhou and Chng 2012). The expression of
TXNIP is increased upon treatment with various anti-cancer agents and it has been shown to
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render cells more sensitive to oxidative stress (Yoshioka et al. 2006). CDC14B is a
phosphatase known to regulate the cell cycle. Its expression was shown to increase upon
treatment with the plant toxin curcumin, which induced DNA damage in lung carcinoma
cells (Skommer et al. 2007). It has also been suggested that CDC14B may be required for
DNA repair of double stranded breaks (Mocciaro et al. 2010; Wei et al. 2011). BHLHB2 has
been previously shown to be upregulated in response to DNA damaging agents in a p53-
independent manner (Thin et al. 2007). It is also a regulator of ionizing radiation-induced
apoptosis and cell death caused by other stress stimuli including hypoxia and serum
starvation (Yamada and Miyamoto 2005). GADD45B is induced by various stress stimuli
including DNA damage, DNA alkylating agents, UVB radiation, and the multi-kinase
inhibitor sorafenib (Ou et al. 2010; Thyss et al. 2005; Zumbrun et al. 2009). Additionally,
GADD45B was induced by treatment with either the verotoxin or shiga toxin 2, toxins
produced by Escherichia coli that inhibit protein synthesis (the shiga toxin 2 is an N-
glycosyidase), in human colorectal carcinoma cells or brain microvascular endothelial cells,
respectively (Bhattacharjee et al. 2005; Fujii et al. 2008). The gene encoding the core
histone protein HIST2H4 was also upregulated in both IM-9 and U266 cells. HIST2H4 can
regulate DNA repair and has been shown to be upregulated by photodynamic therapy, which
induces an increase in cellular ROS levels (Cekaite et al. 2007). Reactive oxygen species
(ROS) can interact with signaling molecules, other proteins, and nucleic acids causing a
variety of changes in growth signaling and cellular damage that can lead to apoptosis or
necrosis (Fogg et al. 2011; Mates et al. 2012; Ray et al. 2012). Specifically, ROS can cause
DNA damage by inducing DNA strand breaks, mutations, deletions, gene amplification, and
rearrangements. The upregulation of the above mentioned genes by b-SO6 delivered into
cells by ch128.1Av suggests that the toxin may increase the oxidative stress level within the
cell through the induction of ROS. Furthermore, these data, together with the fact that
caspase-2 can function in response to DNA damage (Cullen and Martin 2009;
Krumschnabel et al. 2009; Zhivotovsky and Orrenius 2005), is highly activated by
ch128.1Av/b-SO6 (Daniels et al. 2007) suggest that the toxin induces DNA damage in
treated cells.
Treatment with the ch128.1Av/b-SO6 conjugate also upregulated other genes involved in
RNA binding and processing, as well as the inhibition of the NF-κB pathway. THUMPD2
encodes for a methyltransferase with a putative RNA-binding domain whose function is not
understood (Aravind and Koonin 2001). FYTTD1 encodes a protein that is required for
mRNA processing and export from the nucleus to the cytosol (Hautbergue et al. 2009). This
upregulation of proteins involved in RNA binding and processing is understandable as a
compensatory response, given the fact that b-SO6 strongly inhibits protein synthesis.
Additionally, the NF-κB pathway is also affected by b-SO6 treatment. The NF-κB family of
transcription factors play a role in immunity, inflammatory responses, and ultimately cell
growth (Bubici et al. 2006). A unique interaction occurs between ROS and the NF-κB
pathway. Depending on the circumstances, ROS can either induce or inhibit the NF-κB
pathway (Bubici et al. 2006). The activity of these transcription factors is regulated by a
family of inhibitors (IκBs), one of which is encoded by the gene NFKBIE (IκBε) (Li and
Nabel 1997; Whiteside et al. 1997). This inhibitor blocks NF-κB activity by sequestering
certain family members in the cytoplasm and keeping them from translocating to the
nucleus. In our studies, b-SO6 also upregulated the protein encoded by the TSC22D3 gene.
This protein is known to inhibit inflammation (Beaulieu et al. 2010) and NF-κB activity (Di
Marco et al. 2007). Furthermore, TSC22D3 is upregulated by glucocorticoid treatment in
MM cells (Grugan et al. 2008). Moreover, ch128.1Av/b-SO6 upregulates the RGS1 protein
that is known to block signal transduction blocking the activity of GTPase activating
proteins (Bansal et al. 2007). Recently, RGS1 levels increased in plant cells treated with
ozone, which was shown to induce ROS levels (Booker et al. 2012). Taken together, our
data suggest that b-SO6 induces a transcriptional response in malignant B cells consistent
Daniels-Wells et al. Page 8
Toxicol In Vitro. Author manuscript; available in PMC 2014 February 01.
$watermark-text
$watermark-text
$watermark-text
with the induction of oxidative stress/DNA damage that results in the blockage of signal
transduction, cell cycle arrest, and ultimately apoptosis. However, 10 out of the 11 genes
that were upregulated by the ch128.1Av/b-SO6 conjugate were also upregulated by the
protein synthesis inhibitor CHX. This compound interferes with the translocation step in
protein synthesis and thus, inhibits translational elongation. These data suggest that the
observed transcriptional response is not specific to the effects of the toxin per se, but rather,
is a response to a block in protein synthesis.
To our knowledge this is a pioneer study in terms of the gobal expression analysis in cancer
cells treated with SO6 alone or bound to any delivery vehicle. However, a gene expression
analysis has been conducted in human airway cells treated with the native ricin toxin for 24
hours (Wong et al. 2007). This analysis showed the upregulation of a variety of histones;
however, HIST2H4 (upregulated by b-SO6 in our studies) was not one of them. Ricin did
increase the expression of HIST2H2AA and TNFAIP3, which were observed to be
upregulated by b-SO6 in our studies, but only in IM-9 cells. Furthermore, in murine kidney
cells isolated from animals in which ricin was administered intravenously, gene expression
changes included a decrease in ATF4 expression and an increase in ICAM-1 (Korcheva et
al. 2005), which were also differentially expressed in our studies in IM-9 cells only. In
general, the genes upregulated by ricin in these two studies did not overlap with the 11 genes
that were seen to be upregulated in both IM-9 and U266 cells under our study conditions.
In order to confirm the role of ROS in the cell-death mediated by b-SO6, we co-incubated
cells with the antioxidant NAC. Surprisingly, even though b-SO6 is a potent inhibitor of
protein synthesis, the protective effect of NAC was very strong. This suggests that, in
addition to the inhibition of protein synthesis, ROS play a major role in b-SO6-mediated
cytotoxicity. In our study, NAC was unable to block the effects of CHX, even though the
transcriptional response to CHX and the immunotoxin were similar. We observed that
apoptosis induced by CHX occurred at a faster rate and thus, the effects of CHX may have
been too strong for NAC to neutralize. Alternatively, there may be a difference in the type of
ROS generated by the two treatments and NAC can only protect from those induced by b-
SO6. Further studies are needed to understand this phenomenon. The fact that NAC can
block apoptosis induced by our conjugate is consistent with the observation that NAC was
able to block the DNA damage induced by abrin, a Type I RIP similar to b-SO6, in U937
human myeloleukemic cells (Bhaskar et al. 2008). Ricin-induced apoptosis is also mediated
by the generation of ROS in the HeLa human cervical cancer cell line (Rao et al. 2005).
However, ricin has also been shown to cause direct DNA damage that occurs prior to the
induction of apoptosis (Brigotti et al. 2002). CHX was also used in that study and was
shown to block protein synthesis but did not appear to induce DNA damage. This is
consistent with our study showing that NAC did not block the cytotoxic effects of CHX.
Taken together, these studies suggest that while RIPs are potent inhibitors of protein
synthesis, they also induce oxidative stress that contributes their cytotoxic effects.
Although SO6 lacks a cell-binding domain, at high concentrations and under certain
conditions, it can enter cells and cause cytotoxicity (Lombardi et al. 2010). It has been
suggested that in some cases the LDL-related family of receptors may be involved in the
uptake of the natural toxin in mammalian cells. It has also been suggested that the natural
toxin is taken up mostly by receptor-independent endocytosis (Bolognesi et al. 2012). Since
SO6 is known to act on the ribosomes to block protein synthesis, the toxin must ultimately
reach the cytosol. However, its intracellular trafficking is still largely unknown (Lombardi et
al. 2010). It has been suggested that SO6 can remove adenine from DNA through its N-
glycosidase activity (Gasperi-Campani et al. 2005; Roncuzzi and Gasperi-Campani 1996),
although this is controversial (Lombardi et al. 2010). However, if this is the case, SO6 must
reach the nucleus. Although the catalytic activity of SO6 is similar to that of ricin, the
Daniels-Wells et al. Page 9
Toxicol In Vitro. Author manuscript; available in PMC 2014 February 01.
$watermark-text
$watermark-text
$watermark-text
intracellular trafficking of the two toxins clearly differs. Ricin (a Type II RIP that contains a
cell-binding domain) undergoes retrograde transport through the endoplasmic reticulum
where it exploits the ER-associated degradation pathway to reach the cytosol (Spooner et al.
2006; Vago et al. 2005). Previous studies have suggested that saporin (specific isoform not
specified) may traffic through an endosomal compartment due to partial colocalization with
disulphide isomerase, an endoplasmic reticulum marker, in GL15 human glioblastoma cells
(Cimini et al. 2011) and LAMP2, a late endosome marker, in Vero monkey kidney cells
(Vago et al. 2005). Saporin did not colocalize with the early endosome marker EEA1 or the
Golgi marker Golgin 97 (Vago et al. 2005). Another study found SO6 localized
intracellularly within 20 minutes (Bolognesi et al. 2012). At this time SO6 was detected in
endocytic vesicles in the HeLa cytosol accumulating in a perinuclear vesicular structure via
fluorescence microscopy detection. About 30% of SO6 colocalized with the endosomal
compartment (ER marker BiP) while around 7% co-localized with the Golgi apparatus
(Golgi marker GM130) as seen by confocal microscopy. After a 1-hour incubation, 4% of
endocytosed SO6 was detected in the nucleus. Using transmission electron microscopy,
gold-saporin molecules were seen migrating from the plasma membrane and clear vesicles
and vacuoles into perinuclear late endosomes and lysosomes, with approximately 10% of
cells showing saporin nuclear localization (Bolognesi et al. 2012). In addition,
recombinant 125I-SO6 appears to migrate from the cytosol to the nuclear fraction over time
in J774A.1 mouse macrophage cells as detected by immunoblotting (Bagga et al. 2003).
It stands to reason that conjugation of SO6 to a delivery vehicle would alter the natural
trafficking of the toxin at least at the early stages. The delivery of saporin (specific isoform
not specified) conjugated to polyamidoamine dendrimer (PAMAM) coupled with the
photochemical internalization (PCI) technology, which breakdowns endosomal/lysosomal
membranes by activating photosensitizers localized on the membranes, resulted in enhanced
delivery of saporin into Ca9-22 gingival cancer cells (Lai et al. 2008). Furthermore, saporin
was found in the nucleus under these conditions. In our colocalization studies, b-SO6
delivered by ch128.1Av accumulated in cytoplasmic vesicles and did not show a clear and
consistent pattern of intranuclear localization. Since we used only 10 nM of the toxin in our
studies, and such small percentage of saporin has been reported to enter the nucleus, it is
possible that b-SO6 was not clearly observed in the nucleus due to the detection limits of
confocal microscopy. However, we were able to detect b-SO6 in nuclear extracts of treated
cells by Western Blot analysis, although we cannot determine if the toxin is associated with
the nuclear membrane or if it is actually within the nucleus. Since the toxin may have
reached the nucleus, it is possible that it can interact directly with DNA, although we do not
have direct evidence for this at this time. Whether or not b-SO6 directly induces DNA
damage, its high toxicity and inability to enter cells at low concentrations make it a
meaningful therapeutic agent for delivery purposes.
Toxicity to normal cells is always a concern with any anti-cancer drug. In order to address
this concern, we evaluated the toxicity of ch128.1Av/b-SO6 on hematopoietic stem and non-
committed progenitor cells. Our data show that there was no observed toxicity on this
population of cells. This is consistent with the fact that these non-committed progenitors
express very low levels of the TfR1/CD71 (Gross et al. 1997; Knaan-Shanzer et al. 2008;
Lansdorp and Dragowska 1992). We have previously shown that the conjugate is toxic to
late (committed) progenitor cells of both the erythroid and myeloid lineages (CFU-e, BFU-e
and CFU-GM) (Daniels et al. 2011) that are known to express the TfR1 (Daniels et al.
2006b). Our results are consistent with a previous in vitro study (that also used the LTC-IC
assay), which demonstrated the depletion of committed progenitor cells while pluripotent
progenitors were spared if human bone marrow cells were treated with an immuntoxin
composed of SO6 chemically conjugated with the OKT9 antibody that targets the TfR1
(Benedetti et al. 1994). Together, these results suggests that while the immunotoxin may
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have toxicity against committed progenitor cells, these cells can be repopulated by the
pluripotent progenitors that are not affected by treatment with the conjugate. These results
also suggest that the ch128.1Av/b-SO6 conjugate may be a therapeutic option for the ex
vivo purging of cancer cells during autologous stem cell transplantation, a treatment option
for some patients affected with incurable B-cell malignancies such as MM, in which grafts
can be contaminated with MM cells that may shorten progression-free survival (Bashey et
al. 2008; Vogel et al. 2005).
In conclusion, in this study we further examined the mechanism of b-SO6-induced apoptosis
when the toxin is delivered into malignant B cells using ch128.1Av. Our results here suggest
that in addition to its RIP function, b-SO6 induces the generation of ROS, which may play a
role in DNA damage and ultimately the induction of apoptosis in malignant B cells by the
ch128.1Av/b-SO6 conjugate. Our studies confirm the dual activity of ch128.1Av, in that it
can be a direct anti-cancer agent, as well as an effective delivery agent for the transport of
active molecules into cancer cells. Thus, ch128.1Av alone or conjugated to therapeutic
agents should be further explored as a potential therapy for B-cell malignancies.
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Abbreviations
b-SO6 biotinylated saporin-6
BCA bicinchoninic acid
BFU-e burst forming unit-erythroid
BHLHB2 basic-helix-loop-helix transcription factor B2
BMMC bone marrow mononuclear cells
CDC14B dual specificity protein tyrosine phosphatase family
CFU-e colony forming unit-erythroid
CFU-GM colony forming unit-granulocyte/macorphage
CHX cycloheximide
ch128.1Av mouse/human chimeric antibody avidin fusion protein targeting CD71
DNS dansyl hapten (5-dimethylamino naphthalene-1-sulfonyl chloride)
FYTTD1 forty-two-three domain containing 1
GADD45B growth arrest DNA damage-inducible gene 45β
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GAPDH glyceraldehyde 3-phosphate dehydrogenase
HIST2H4 core histone 2H4
HRP horseradish peroxidase
kDa kilodlatons
KLF6 Kruppel-like transcription factor 6
LFC log base 2-fold change
LTC-IC long-term culture-initiating cell
MM multiple myeloma
mw molecular weight
NAC N-acetylcysteine
NFKBIE NF-κB inhibitor epsilon (IκBε)
NHL non-Hodgkin’s lymhoma
NIH National Institutes of Health
QPCR quantitative polymerase chain reaction
RGS1 regulator of G-protin signaling
RIP ribosomal-inactivating protein
ROS reactive oxygen species
SO6 saporin-6
TBP TATA-box binding protein
Tf transferrin
TfR1 transferrin receptor 1 (also known as CD71)
THUMD2 THUMP domain containing 2
TSC22D3 glucocorticoid-induced leucine zipper; TFGβ-stimulated clone 22 domain
TXNIP thioredoxin interacting protein
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Figure 1. Time course protocol for mRNA isolation and verification of the cytotoxic effects of the
fusion protein alone and conjugated to b-SO6
Cells were treated with 10 nM ch128.1 alone or conjugated to b-SO6 for the indicated times
in duplicate samples in a 48-well plate at 200,000 cells/well (A). At each time point RNA
was collected for microarray analysis. Control wells were treated with buffer alone.
Additional wells for each treatment were incubated in parallel for 48 hours to measure the
anti-proliferative (B) and pro-apoptotic (C) effect of ch128.1Av and ch128.1Av/b-SO6 on
IM-9 and U266 cells. The anti-proliferative effect was measured by [3H]-thymidine
incorporation and values expressed as the % of buffer control. Error bars represent standard
deviation. Apoptosis was determined by flow cytometry in cells labeled with Annexin-V/
Propidium Iodide. Percentage of total cells is shown in the corner of each quadrant.
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Figure 2. Gene expression analysis in cells treated with ch128.1Av complexed to b-SO6
Changes in gene expression with a greater than 1.0 Log base 2-fold change (LFC) after 1, 3,
9, or 24 hours of ch128.1Av/b-SO6 treatment with respect to their time matched control
(buffer alone) are shown for IM-9 (A) and U266 (B) cells clustered by time point and
magnitude of change. Changes in IM-9 greater than 1.0 LFC at 9 hours (C) post treatment
are also shown for comparison with changes in U266 at 24 hours. Clustering was conducted
using the Cluster program and visualized using Java TreeView.
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Figure 3. Comparison of gene expression changes in IM-9 and U266 at the various time points
Direct comparison in gene expression changes between IM-9 and U266 cells treated with
ch128.1Av/b-SO6 in which genes with a variance greater than 0.4 are clustered over the
various time points and the magnitude of difference between the RNA levels in each cell
line. In this case genes whose transcripts are present at a higher level in U266 than in IM-9
are shown in yellow. Clustering was conducted using the Cluster program and visualized
using Java TreeView.
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Figure 4. Gene clustering according to ontologies
The same list of genes shown in Figure 3 are now shown clustered by their corresponding
ontologies, with statistically enriched ontologies listed at right alongside their corresponding
p-values. Clustering was conducted using the Cluster program and visualized using Java
TreeView.
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Figure 5. Validation of gene expression changes by real time PCR
Freshly isolated RNA from U266 (A) and IM-9 (B) cells treated with either 10 nM
ch128.1Av, b-SO6, or ch128.1Av/b-SO6 for 24 hours was converted to cDNA and gene
expression determined using relative quantification analysis on a Roche LightCycler 480
System. Data is shown as the fold change in target gene expression compared to the
housekeeping gene GAPDH. All samples were tested in triplicate and the standard
deviations are shown. Data are representative of two independent experiments carried out
with different RNA preparations.
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Figure 6. Protection of ch128.1Av/b-SO6-induced cell death by the antioxidant NAC
IM-9 (left panels) and U266 (right panels) cells were treated with 10 nM (top panels) or 1
nM (bottom panels) ch128.1Av, b-SO6, or ch128.1Av/b-SO6 for 48 hours with or without
the addition of 2 mM NAC. CHX was used as a common protein synthesis inhibitor. The
percentage of Annexin V positive cells was determined using flow cytometry. Data are the
average of three independent experiments. Error bars indicate the standard deviation. * p <
0.01, Student’s t-test.
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Figure 7. Detection of b-SO6 in nuclear extracts of cells treated with ch128.Av/b-SO6 conjugate
U266 (left panels) and IM-9 (right panels) were treated with 10 nM ch128.1Av/b-SO6 for
either 1 hour or 16 hours followed by the preparation of nuclear and cytoplasmic extracts.
Saporin within these extracts was detected by Western Blot analysis. Control cells (“C”)
were incubated with an equal amount of buffer for 16 hours. GAPDH was used a control for
cytoplasmic protein, while TBP was used as a control for nuclear protein.
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Table 1
Gene, probe, and primer information for real time PCR analysis.
Gene Accession # UPL Probe # 5′ Primer 3′ Primer
TXNIP NM_006472.3 85 cttctggaagaccagccaac gaagctcaaagccgaacttg
CDC14B AF023158.1 66 gggtgccattgcagtacatt agatcctgacccacgcaat
RGS1 NM_002922.3 84 tgaaatcttccaagtccaagg tccaaagacattttgaccagttt
GADD45β AF087853.1 10 cattgtctcctggtcacgaa taggggacccactggttgt
HIST2H4 AF525682.1 25 gagtgagagggacctgagca cctctcgacatttcgtcattt
BHLHB2 AB043885.1 66 tggattcccctgagttaaggt tcaggaaaatcctttgacagataa
TSC22D3 BC072446.1 10 tggtggccatagacaacaag tctcggatctgctccttcag
KLF6 BC000311.2 85 gatgagttaaccaggcacttcc agaggtgcctcttcatgtgc
NFKBIE ENST00000275015.4 79 gctctgttgcctggcttt agccagatggagtgctgtct
FYTTD1 BC039734.1 25 gcaatgaaaacctcgacaaaa attgctgggcaccacttt
THUMP2 BC013299.2 86 gacttgactttcagagtatcttgtcg aattccaattacttttcctacctcct
UPL: universal probe library (Roche Applied Sciences)
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Table 2
Comparison of microarray and QPCR data for the 11 genes commonly upregulated in IM-9 and U266 cells.
Gene U266 Micoarray (Fold
Change)
U266 QPCR (Fold
Change)
IM-9 Microarray (Fold
Change)
IM-9 QPCR (Fold
Change)
TXNIP 3.0 8.2 8.4 22.4
CDC14B 2.9 2.2 15.2 2.9
HIST2H4 2.3 2.0 9.4 5.7
RGS1 4.1 14.5 6.8 18.8
THUMPD2 2.1 5.3 3.6 6.2
KLF6 2.3 5.6 4.6 8.6
BHLHB1 2.0 2.9 2.9 1.9
FYTTD1 2.1 2.0 3.5 2.5
GADD45B 2.1 13.1 13.5 25.5
TSC22D3 2.9 12.8 2.9 8.1
NFKBIE 2.1 4.9 6.4 7.5
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Table 3
Effect of ch128.1Av on normal pluripotent hematopoietic progenitor cells from three separate donors as
determined by the LTC-IC assay.
Donor 1 Donor 2 Donor 3
Untreated 7 ± 0.96 1 ± 0.82 13 ± 1.71
Buffer 13 ± 1.00 3 ± 1.83 ND
ch128.1Av 15 ± 2.20 3 ± 1.50 13 ± 2.16
b-SO6 15 ± 2.63 9 ± 2.08 21 ± 1.15
IgG3-Av/b-SO6 10 ± 1.83 8 ± 1.71 20 ± 2.71
ch128.1Av/b-SO6 12 ± 1.50 10 ± 2.65 21 ± 2.5
Data represent the mean of quadruplicates ± the standard deviation. LTC-IC indicates long-term cell-initiating culture; ND, not determined. Data
for the untreated, buffer, and ch128.1Av alone have been previously reported (Daniels et al. 2011). All samples were tested simultaneously in each
donor.
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